You have searched for "dexamethasone"
Showing 11-20 of 226
Among the treatments recently received by the current US president for his infection was an experimental antibody cocktail.
SINGAPORE, Oct 20 (The Straits Times/ANN): The National Centre for Infectious Diseases (NCID) has temporarily stopped enrolling Covid-19 patients for a monoclonal antibody trial after the American pharmaceutical company that developed the drug had to halt the trial due to safety concerns last week.
PETALING JAYA: Dexamethasone, which is used for pneumonia patients, is more effective in treating Covid-19 than remdesivir and the HIV/AIDS drugs lopinavir or ritonavir, says Health director-general Tan Sri Dr Noor Hisham Abdullah.
WASHINGTON, Oct. 16 (Xinhua) -- The U.S. National Institutes of Health (NIH) has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19, said a statement of the agency on Friday.
GENEVA, Oct. 16 (Xinhua) -- Latest results from an international trial coordinated by the World Health Organization (WHO) on four COVID-19 therapeutic drugs indicated that they have "little or no" effect in preventing death from COVID-19 or reducing time in hospital, the WHO said on Friday.
WASHINGTON (Reuters) - President Donald Trump's 14-year-old son, Barron, tested positive for COVID-19 but exhibited no symptoms after both of his parents contracted the virus, first lady Melania Trump said on Wednesday.
Donald Trump declares himself ‘immune’ from Covid-19, calling his aggressive treatment ‘pretty routine’
HONG KONG, Oct 12 (SCMP): Trump said he was feeling ‘fantastically’ and he will add more states to his campaign itinerary in coming weekKey data for evaluating Trump‘s health has not been made available
SINGAPORE (The Straits Times/ANN): Hospitalised Covid-19 patients here will now have a new treatment option: to take part in Singapore's first phase three monoclonal antibody trial.
AMSTERDAM/WARSAW/BRUSSELS (Reuters) - European countries are facing shortages of COVID-19 drug remdesivir because limited supplies are running out, officials said, with cases surging and the United States having bought up most of drugmaker Gilead's output.